🇺🇸 FDA
Patent

US 9969803

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

granted A61KA61K2039/505A61K39/3955

Quick answer

US patent 9969803 (Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof) held by The Board of Regents of the University of Oklahoma expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2039/505, A61K39/3955, A61K45/06, A61K9/0048